Jinsil K. Sung, MD

Specializing in Hand, Wrist and Elbow

About
Dr. Sung:

Dr. Jinsil Sung is a Board Certified Orthopaedic Surgeon specializing in hand and upper extremity for both adult and pediatric patients. Her clinical interests include both acute injuries, such as fractures and lacerations, as well as more chronic ailments, such as arthritis, Dupuytren’s disease, and nerve dysfunction. Dr. Sung grew up in Maryland but completed her undergraduate degree at MIT where she received a Bachelor of Science in Chemistry. She then received her medical degree from the University of Maryland School of Medicine where she was a Dean’s Scholarship Recipient and a Hans R. Wilhelmsen Prize Winner for Outstanding Achievement in Surgery.

Learn More About Dr. Sung:

Physician Bio:

Dr. Jinsil Sung is an orthopaedic surgeon specializing in hand and upper extremity for both adult and pediatric patients. Her clinical interests include both acute injuries, such as fractures and lacerations, as well as more chronic ailments, such as arthritis, Dupuytren’s disease, and nerve dysfunction. Dr. Sung grew up in Maryland but completed her undergraduate degree at MIT where she received a Bachelor of Science in Chemistry. She then received her medical degree from the University of Maryland School of Medicine where she was a Dean’s Scholarship Recipient and a Hans R. Wilhelmsen Prize Winner for Outstanding Achievement in Surgery.

Dr. Sung completed her Orthopaedic Surgery residency at Boston University Medical Center and finished her fellowship in Hand, Microvascular, and Upper Extremity Surgery at Brown University. She is Board Certified in Orthopaedic Surgery and holds a Subspecialty Certification in Hand Surgery. Dr. Sung is a fellow of the American Academy of Orthopaedic Surgery, serves on the Board of the Massachusetts Orthopaedic Society, and is a member of the American Society for the Surgery of the Hand, New England Hand Society, and New England Orthopaedic Society.

Prior to joining Boston Orthopaedics and Spine, Dr. Sung was Chief of Hand Surgery at Norwood Hospital. She has been named Best of Boston in Hand Surgery for 2017, 2019, 2020, 2021 and 2022, Exceptional Women in Medicine in 2019-2021, and a Castle Connolly Top Doctor- 5 years.

Specialties:

Upper Extremity including conditions and surgery of:
– Hand
– Wrist
– Tennis Elbow
– Ganglion Cyst
– Trigger finger
– Dupuytren’s Contracture
– Osteo-Arthritis of the hand and wrist
– Lateral Epicondylitis
– Chronic deformities of the hand

Education

Education

Medical School

  • University of Maryland School of Medicine (Graduation 5/23/2003)

Post Graduate

  • Boston Medical Center, Intern:General Surgery
  • Boston Medical Center, Resident: Orthopedic Surgery
  • Brown University Rhode Island Hospital:Hand, Upper Extremity and Microvascular Surgery Fellowship
Achievements

Board Certifications:

Board Name General Certification Subspecialty
Orthopaedic Surgery Orthopaedic Surgery Surgery of the Hand

Honors and Awards:

  • First place poster in Practice Management at the AAOS Annual Meeting (2006)
  • 2024 Boston Magazine Top Doctor 
  • 2023 Boston Magazine Top Doctor 
  • 2022 Boston Magazine Top Doctor 
  • 2021 Boston Magazine Top Doctor 
  • 2020 Boston Magazine Top Doctor 
  • 2019 Boston Magazine Top Doctor 
  • 2017 Boston Magazine Top Doctor 
  • 2024 Exceptional Women in Medicine
  • 2023 Exceptional Women in Medicine
  • 2022 Exceptional Women in Medicine
  • 2021 Exceptional Women in Medicine
  • 2020 Exceptional Women in Medicine
  • 2019 Exceptional Women in Medicine
  • Castle Connolly Top Doctor – 10 Years
Publications

  • Reuse of external fixation components: a randomized trial. Journal of Orthopaedic Trauma. 2008 Feb.
  • The orthopaedic trauma literature. BMC Musculoskeletal Disorders. 2008 Jan.
  • Refurbished external fixators as good as new. Orthopaedics Today. November 14, 2005.
  • Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J of Trauma.
  • Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J of Trauma.
  • Admission serum albumin is predictive of outcome in critically ill trauma patients. Am Surgeon 2004
  • Thumb Carpometacarpal Arthritis. Techniques in Orthopaedics: Mar 2009 – Vol 24 – Issue 1- p.23-25
  • Sung J,Akelman E. Thumb Carpometacarpal Arthritis. Techniques in Orthopaedics:March 2009 – Volume 24 – Issue 1 – pp 23-26.
  • Sung J, Akelman E. Thumb Carpometacarpal Arthritis. Techniques in Orthopaedics:March 2009 – Volume 24 – Issue 1 – pp 23-26.
  • Sung J,Levin R, Siegel J, Creevy W, Einhorn T, Tornetta P. Reuse of external fixation components: a randomized trial. Journal of Orthopaedic Trauma. 2008 Feb;22(2):126-30; discussion 130-1.
  • Featured article by DiMarcantonio. Refurbished external fixators as good as new. Orthopaedics Today. November 14, 2005.
  • Sung J,Bochicchio GV , Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. Journal of Trauma. 2005 Jul;59(1):80-3.
  • Bochicchio GV,Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. Journal of Trauma. 2005 May;58(5):921-4.
  • Sung J, Bochicchio GV, Joshi M, Bochicchio K, Costas A, Tracy K, Scalea TM. Admission serum albumin is predictive of outcome in critically ill trauma patients. American Surgeon. 2004 Dec;70(12):1099-102.
    Available Locations

    – Cambridge
    – Waltham

    Trusted by Top Teams & Healthcare Institutions

    Boston Celtics Team Physicians
    Top Orthopedic Doctors in Boston, MA

    Take the First Step

    Get an accurate diagnosis and treatment plan
    from our expert physician team.

    Attention: Starting January 1, 2024, Boston Orthopaedic & Spine will no longer stock viscosupplementation medication (such as Euflexxa, Orthovisc, etc). In the past, we had these medications in stock to accommodate insurances that did not require prior authorizations. Going forward, our physicians are happy to write prescriptions in which patients can send to local pharmacies to fill and bring to the office for our physicians to inject. Thank you!
    Attention: Starting January 1, 2024, Boston Orthopaedic & Spine will no longer stock viscosupplementation medication (such as Euflexxa, Orthovisc, etc). In the past, we had these medications in stock to accommodate insurances that did not require prior authorizations. Going forward, our physicians are happy to write prescriptions in which patients can send to local pharmacies to fill and bring to the office for our physicians to inject. Thank you
    Call Now Button